Journals / Türk Mikrobiyoloji Cemiyeti Dergisi / 2007 / Cilt: 37 - Sayı: 2

Ailesel Akdeniz Ateşi hastalarında serum antigliadin ve antiendomisiyum antikorlarının karşılaştırılması

Comparison of serum antigliadin and antiendomysium antibodies in patients with Familial Mediterranean Fever

Pages
98–102
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In order to determine the accuracy of AGA and EmA antibodies for the diagnosis of CD in FMF children with digestive symptoms, it is necessary to search for these antibodies among larger FMF patient group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study was conducted to investigate the prevalence and clinical relevance of antiendomysium (EmA) and antigliadin (AGA) antibodies at the onset of Familial Mediterranean Fever (FMF) patients by serological methods.
📊
Key Findings & Data:A total of 25 children ( ages between 5 to 17 years ) were included in this study.
💡
Conclusion & Impact:In order to determine the accuracy of AGA and EmA antibodies for the diagnosis of CD in FMF children with digestive symptoms, it is necessary to search for these antibodies among larger FMF patient group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

This study was conducted to investigate the prevalence and clinical relevance of antiendomysium (EmA) and antigliadin (AGA) antibodies at the onset of Familial Mediterranean Fever (FMF) patients by serological methods. The high levels of AGA and EmA have been reported in patients with severe abdominal pain. Although it has been pointed out that coeliac disease (CD) has been shown to be associated with many different diseases, the relationship between the CD and FMF, in which main sign is abdominal pain, has not been investigated so far. A total of 25 children ( ages between 5 to 17 years ) were included in this study. Fifteen of them were FMF patients having abdominal cramps and discomfort, ten were healthy controls. AGA IgA and IgG antibodies were detected by a commercial ELISA (Euroimmun), EmA IgA and AGA IgA antibodies were determined by indirect immunofluorescence test (IFA, Euroimmun). Six (40%) FMF patients were found positive for AGA IgG, two (13.3%) were found positive for AGA IgA by ELISA, four (26.6%) were positive for EmA IgA and two (13.3%) were positive for AGA IgA antibodies by IFA. Statistical analysis revealed that there was statistical difference ( p= 0.05, Fisher's chi-square test) for AGA IgG antibodies by ELISA between FMF patients and controls. There was no statistical difference for AGA IgA by ELISA, AGA IgA and EmA IgA by IFA,. Those found to be AGA IgG and IgA positive and/or EmA IgA positive by both methods could not be further investigated with the intestinal biopsy. In order to determine the accuracy of AGA and EmA antibodies for the diagnosis of CD in FMF children with digestive symptoms, it is necessary to search for these antibodies among larger FMF patient group.

Özet

Bu çalışma ailesel akdeniz ateşi ( FMF ) hastalarında antiendomisyum ( EmA) ve antigliadin ( AGA) antikorlarının prevalansının ve klinikle ilişkisinin serolojik yöntemlerle araştırılması amacıyla gerçekleştirilmiştir. Karın ağrısı olan hastalarda AGA ve EmA 'nın düzeylerinin yüksek olduğu bildirilmiştir. Çölyak hastalığının ( CD ) pek çok farklı hastalıkla ilişkili olduğuna dikkat çekilmiş olmakla birlikte en önemli belirtinin karın ağrısı olduğu CD ve FMF arasındaki ilişki yeterince araştırılmamıştır. Bu çalışma kapsamına 25 çocuk ( % - 17 yaş arası ) alınmıştır. Bunlardan 15 ' i FMF hastası olup karın krampları ve discomfort şikayetleri vardır; 10 çocuk ise sağlıklı kontrol grubunu oluşturmuştur. AGA İgA ve İgG antikorları ELISA ( Euroimmun ) , EmA İgA ve AGA İgA antikorları indirekt immunfloresan testi ( IFA , Euroimmun ) uyarınca saptanmıştır. ELISA yöntemiyle FMF hastalarından altısı ( % 40 ) AGA İgG , ikisi ( % 13.3 ) AGA İgA açısından pozitif bulunmuştur ; dört hasta ( % 26.6 ) EmA İgA ve iki hasta ( ( % 13.3 ) AGA İgA antikorları için IFA yöntemiyle pozitif olarak belirlenmiştir. FMF hastaları ve kontrol grup arasında ELISA yöntemiyle saptanan AGA İgG antikorları açısından saptanan fark istatistiksel olarak anlamlı ( p= 0.05 , Fischer ki-kare testi ) bulunmuştur.ELISA yöntemiyle belirlenen AGA İgA , IFA yöntemiyle AGA İgA ve EmA İgA anasındaki fark anlamlı bulunmamıştır. Her iki yöntemle de AGA İgG ve İgA pozitif ve/veya EmA İgA pozitif bulunanlar intestinal biyopsi ile daha ileri incelemeye tabi tutulamamışlardır. Sindirim sistemi semptomları bulunan çocuklarda CD ve FMF ' tanısı için AGA ve EmA antikorlarının öneminin belirlenmesi amacıyla bu antikorların daha çok sayıda FMF hastalarında araştırılması gereklidir.

🔖

Cite This Article

DOĞAN, Y., SARIOĞLU, S., YILMAZ, Ö., BAHAR, İ. H., YULUĞ, N., KIRDAR, S., ÜNSAL, E., KAVUKÇU, S. (2022). Ailesel Akdeniz Ateşi hastalarında serum antigliadin ve antiendomisiyum antikorlarının karşılaştırılması. Türk Mikrobiyoloji Cemiyeti Dergisi, Cilt: 37 - Sayı: 2, 98–102. https://ajindex.com/articles/635990

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Jabri B, Sollid LM. Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol 2006; 3:516-25
  2. Kamaeva OI, Reznikov Iu P, Pimenova NS. Dobritsyna LV. Antigliadin antibodies in the absence of celiac disease. Klin Med 1998; 76:33-35
  3. De Wal Y, Kody Y, Veelen PV, Vader W, Koning F. Coeliac disease: It takes three to tango! Gut 2000; 46: 734-737
  4. Sategna-Guidetti C, Bruno M, Pulitano R, Ferfoglia G. Disease specifity of IgA class anti-endomysium antibodies (IgAEmA) in adult coeliac disease. Eur J Gastroenterol Hepatol 1991; 3: 251-254
  5. Catassi C, Fabiani E, Gasparin M, Troncone R. Quantitative antigliadin antibody measurement in clinical practice. Ital J Gastroenterol Hepatol 1999; 31: 366-370
  6. Bürgin-Wolff A, Berger R, Gaze H, Huber H, Lentze MJ, Nussle D. IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study. Eur J Pediatr 1989; 148: 496-502
  7. Carlsson AK, Axelsson IEM, Borulf SK, Bredberg ACA, Lindberg BA, Sjöberg KG, Ivarsson SA. Prevalence of IgAantiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in swedish children and adolescents. Pediatrics 1999; 103:1248-1252
  8. Hill I, Fasano A, Schwartz R, Counts D, Glock M, Horvath K. The prevalence of celiac disease in at-risk groups of children in the United States. J Pediatr 2000; 136: 86-90
  9. Livaeh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M. Establishment of a new set of criteria for the classification of familial Mediterranean fever (FMF). In Sobar E, Gafni J, Pras M. Familial Mediterranean Fever. 1st International Conference Jerusalem Israel, Freund Publishing House Ltd. London 1997: 703-206
  10. Grand RJ. Celiac disease. Then and now. 21st Annual CSA Conference, Warwick, RI, Lifeline 1999; XV:1-2
  11. Picarelli A, Triglione P, Mariani P, Di Giovambattistita F, Greco M, Gurnari M, Paoluzi P, Bonamico M, Ballati G. Use of a threshold serum level of anti-gliadin antibodies improves diagnostic efficiency of the test in adult coeliac disease but is unrelaible as a screening test. Ital J Gastroenterol 1996; 28: 70-75
  12. Meloni GF, Dessole S, Vargiu N, Tomasi PA, Musumeci S. The prevalance of coeliac disease in infertility. Hum Reprod 1999; 14: 2759-2761
  13. Falchuk ZM. The hows and whys of celiac disease. 21st Annual CSA Conference, Warwick, RI. 1999; XVII: 1-4
  14. Johnston SD, Watson RG, McM